BetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, California
25 avr. 2023 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
20 avr. 2023 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Sarah Tanksley tekur sæti í stjórn Alvotech hf. og Sandra Casaca skipuð framkvæmdastjóri gæðamála
19 avr. 2023 17h30 HE
|
Alvotech
Alvotech (NASDAQ: ALVO) tilkynnti í dag breytingar á skipulagi gæðastjórnunar Alvotech. Sandra Casaca hefur verið skipuð framkvæmdastjóri gæðamála. Sarah Tanksley tekur sæti í stjórn Alvotech hf.,...
Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer
19 avr. 2023 17h30 HE
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced changes to the company’s Quality...
Alvotech birtir nýjar upplýsingar um stöðu umsóknar um markaðsleyfi í Bandaríkjunum fyrir AVT02
13 avr. 2023 20h45 HE
|
Alvotech
Alvotech (NASDAQ: ALVO) hefur borist bréf frá Matvæla- og lyfjaeftirliti Bandaríkjanna (FDA) sem varðar umsókn fyrirtækisins um markaðsleyfi fyrir AVT02 sem líftæknilyfjahliðstæðu við Humira®...
Alvotech Provides Regulatory Update on AVT02 Biologics License Application
13 avr. 2023 20h45 HE
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug...
Mitsui Acquires Convertible Bonds Issued by Alvotech and Forges Strategic Healthcare Collaboration Agreement with Aztiq
11 avr. 2023 20h00 HE
|
Aztiq Consulting ehf.
TOKYO and LONDON, April 12, 2023 (GLOBE NEWSWIRE) -- Mitsui & Co., Ltd. ("Mitsui") has acquired convertible bonds worth approximately US $62.75 million (¥8.6 billion) issued by Luxembourg-based...
BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article
29 mars 2023 08h00 HE
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
Alvotech birtir nýjar upplýsingar um sjálfbærni og samfélagslega ábyrgð
28 mars 2023 05h00 HE
|
Alvotech
Alvotech hefur birt nýjar upplýsingar um sjálfbærni og samfélagslega ábyrgð, þar á meðal mælikvarða umhverfis-, samfélags- og stjórnarhátta (ESG) fyrir árið 2022. „Markmið okkar er að bæta aðgengi...
Alvotech Provides Update on Corporate Sustainability Framework
28 mars 2023 05h00 HE
|
Alvotech
Alvotech (Nasdaq: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced an update to the...